Drugs / RGD-K5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03364270 | Oct 2018 → Feb 2020 | internal carotid artery stenosis | Balaji Tamarappoo | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RGD-K5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03364270 ↗ |
| Modality | Diagnostic / imaging agent | “[F-18] RGD-K5 is a radioactive tracer used in imaging” NCT03364270 ↗ |
| Route | Intravenous | “through this IV catheter that the dose of \[F-18\] RGD-K5 will be given” NCT03364270 ↗ |